» Articles » PMID: 39334913

Sheng Xue Ning As a Novel Agent That Promotes SCF-Driven Hematopoietic Stem/Progenitor Cell Proliferation to Promote Erythropoiesis

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 Sep 28
PMID 39334913
Authors
Affiliations
Soon will be listed here.
Abstract

Stimulating erythropoiesis is essential in the treatment of various types of anemia. Sheng Xue Ning (SXN) is commonly used in China as an iron supplement to treat iron deficiency anemia, renal anemia, and anemia in pregnancy. This research reports a novel effect of SXN in enhancing the proliferation of hematopoietic stem/progenitor cell (HSPC) to promote erythropoiesis in the bone marrow, which is distinct from conventional iron supplements that primarily aid in the maturation of red blood cells. Employing a model of hematopoietic dysfunction induced by X-ray exposure, we evaluated the efficacy of SXN in restoring hematopoietic function. SXN significantly promoted the recovery of peripheral erythroid cells and enhanced the proliferation and differentiation of Lin/c-KIT/Sca-1 HSPC in mice exposed to X-ray irradiation. Our results showed that SXN elevated the expression of stem cell factor (SCF) and activated the SCF/c-KIT/PI3K/AKT signaling pathway, facilitating the proliferation and differentiation of HSPC. In vitro, SXN markedly enhanced the proliferation of bone marrow nucleated cell (BMNC) and the colony-forming capacity of BFU-E, CFU-E, and CFU-GM, while also elevating the expression of proteins involved in the SCF/c-KIT/PI3K/AKT pathway in BMNC. Additionally, SXN enhanced the proliferation and differentiation of mesenchymal stem cell (MSC) and increased SCF secretion. In conclusion, SXN demonstrates the capacity to enhance erythropoiesis by upregulating SCF expression, thereby promoting HSPC proliferation and differentiation via the SCF/c-KIT/PI3K/AKT pathway. SXN may offer a new strategy for improving the activity of HSPC and promoting erythropoiesis in the treatment of hematopoiesis disorders.

References
1.
Zsebo K, Williams D, Geissler E, Broudy V, Martin F, Atkins H . Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 1990; 63(1):213-24. DOI: 10.1016/0092-8674(90)90302-u. View

2.
Pinho S, Frenette P . Haematopoietic stem cell activity and interactions with the niche. Nat Rev Mol Cell Biol. 2019; 20(5):303-320. PMC: 6483843. DOI: 10.1038/s41580-019-0103-9. View

3.
Sui X, Krantz S, Zhao Z . Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br J Haematol. 2000; 110(1):63-70. DOI: 10.1046/j.1365-2141.2000.02145.x. View

4.
Kent D, Copley M, Benz C, Wohrer S, Dykstra B, Ma E . Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential. Blood. 2009; 113(25):6342-50. DOI: 10.1182/blood-2008-12-192054. View

5.
Suryavanshi S, Sharma D, Checker R, Thoh M, Gota V, Sandur S . Amelioration of radiation-induced hematopoietic syndrome by an antioxidant chlorophyllin through increased stem cell activity and modulation of hematopoiesis. Free Radic Biol Med. 2015; 85:56-70. DOI: 10.1016/j.freeradbiomed.2015.04.007. View